SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-22-000067
Filing Date
2022-05-13
Accepted
2022-05-13 16:19:41
Documents
2
Period of Report
2022-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165247311184773.html 4  
1 FORM 4 wf-form4_165247311184773.xml 4 4770
2 EDICK, PAUL R POA ex-24.htm EX-24 2977
  Complete submission text file 0001867096-22-000067.txt   9134
Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 22923013

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations